Recommendations for Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy

JAMA. 2021 Sep 21;326(11):1058-1059. doi: 10.1001/jama.2021.7458.

Authors

Benjamin A Derman¹, Andrew M Davis²

Affiliations

¹ Section of Hematology/Oncology, University of Chicago, Chicago, Illinois.
² Department of Medicine, University of Chicago, Chicago, Illinois.

PMID: 34546311
DOI: 10.1001/jama.2021.7458

No abstract available

MeSH terms

Adult
Antineoplastic Agents / administration & dosage
Antineoplastic Agents / adverse effects*
Cancer Survivors*
Duloxetine Hydrochloride / therapeutic use*
Humans
Peripheral Nervous System Diseases / chemically induced*
Peripheral Nervous System Diseases / drug therapy
Peripheral Nervous System Diseases / prevention & control
Practice Guidelines as Topic*
Serotonin and Noradrenaline Reuptake Inhibitors / therapeutic use*

Substances

Antineoplastic Agents
Serotonin and Noradrenaline Reuptake Inhibitors
Duloxetine Hydrochloride